SLR Investment

Q2 FY2026 EarningsQ2 FY2026 results missed consensus across the board, with total investment income of $48.82M vs. $48.82M expected (in-line) and GAAP EPS of $0.15 vs. $0.34 expected. Normalized EPS of $0.33 was slightly below the $0.33 consensus. The significant miss in GAAP bottom-line figures was primarily driven by $9.3M in net unrealized losses on the investment portfolio. NAV per share declined to $18.00 from $18.26 at year-end 2025, reflecting portfolio depreciation in certain life science and specialized finance holdings.